Status:
COMPLETED
Excimer Light in Psoriasis
Lead Sponsor:
Cairo University
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to determine the standard tissue levels of SP and its receptor in lesional skin of psoriasis patients in both developing and stationary stages before and after excimer light t...
Eligibility Criteria
Inclusion
- Type of Psoriasis: plaque psoriasis.
- Less than 10% surface area.
Exclusion
- Erythrodermic psoriasis
- Pustular psoriasis
- Topical treatment for psoriasis for the past 2 weeks.
- Systemic retinoids in the last 2 years.
- Systemic treatments (including any drugs that affect SP level as Aprepitant) in the last 3 months.
- Contraindications to excimer light therapy (history of skin malignancy or precancerous conditions like xeroderma pigmentosum or photosensitivity)
Key Trial Info
Start Date :
March 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05283876
Start Date
March 10 2022
End Date
March 30 2023
Last Update
February 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Al Ainy Faculty of medicine
Cairo, Egypt